Glycogen storage diseases

From Libre Pathology
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Glycogen storage diseases a group of diseases characterized by the accumulation of glycogen.

Clinical picture

  • Exercise intolerance
  • Usually due to specific muscle enzyme defects

DDx:

  • Mitochondriopathies
  • Carnitine palmitoyltransferase II (CPT2) deficiency

General microscopic

Features:[1]

  • +/-Vacuolated muscle fibres.
  • acid phosphatase+ve in vaculoes.
  • PAS+ve.

Images:

  • Abnormal glycogen is not easy to spot in this muscle biopsy HE stain (WC/jensflorian)

  • Intramuscular glycogen is usually PAS+++ve (WC/jensflorian)

  • Lack of staining in intramuscular deposits, Trichrom Gömöri (WC/jensflorian)

  • Lafora-like polyglucosan bodies in the CNS, low magnification (WC/jensflorian)

  • Lafora-like polyglucosan bodies in the CNS, higher magnification(WC/marvin101)

  • Large vacuoles in the liver, HE stain (WC/Netha Hussain)

Electron microscopy

  • Electron dense deposits.

Specific diseases

Pompe disease

  • AKA glycogen storage disease type II, AKA acid maltase deficiency, AKA alpha-1,4-glucosidase deficiency.[2]

General

  • Deficiency of alpha-1,4-glucosidase; it degrades glycogen to glucose in lysosomes.
  • Autosomal recessive inheritance.
  • Identified in 1932 by dutch pathologist Johannes C. Pompe.[3]
  • A enzyme replacement therapy exists. [4]

Clinical

  • infantile onset (usually at age 4-8months):
    • Floppy baby.
    • Macroglossia.
    • Hepatomegaly.
    • Big heart - often early death from cardiac failure.
  • late onset (usually at age 1-2years):
    • Progressive muscle weakness (myopathy).
    • Usually only mild cardiac involvement.

Note: clinical course correlates with remaining enzyme activity.[5]

Diagnosis

  • Mutations in acid alpha-glucosidase.
  • Elevated serum CK (<10x).
  • Cytoplasmic (lysosomal) vacuoles (Acid phosphatase +ve).
  • Muscle fibers with vacuoles enlarged.
  • Type 1 fibers more often affected.
  • PAS+ve deposits.
  • Autophagic (Lysosomal) vacuoles in electron microscopy.

  • Large vacuoles in Pompe disease (H&E, WC/jensflorian)

  • Clinical phenotype in Pompe disease (WC/Wens et. al.)

Cori disease

  • AKA glycogen storage disease type III.[6]

General

  • Hepatomegaly.

Microscopic

Features:

  • Hypertrophic hepatocytes with pale cytoplasm.
    • Classically: PAS +ve, PAS-D -ve.
  • Portal fibrosis.

Image:

Stains

See also

References

  1. ↑ URL: http://neuromuscular.wustl.edu/pathol/acidmchi.htm. Accessed on: 11 January 2011.
  2. ↑ URL: http://www.ncbi.nlm.nih.gov/omim/606800. Accessed on: 11 January 2011.
  3. ↑ Pompe J-C. Over idiopatische hypertropie van het hart. Ned Tijdscr Geneeskd 1932; 76:304.
  4. ↑ Amalfitano, A.; Bengur, AR.; Morse, RP.; Majure, JM.; Case, LE.; Veerling, DL.; Mackey, J.; Kishnani, P. et al. "Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial.". Genet Med 3 (2): 132-8. doi:10.109700125817-200103000-00007. PMID 11286229.
  5. ↑ Hermans, MM.; van Leenen, D.; Kroos, MA.; Beesley, CE.; Van Der Ploeg, AT.; Sakuraba, H.; Wevers, R.; Kleijer, W. et al. (Jan 2004). "Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II.". Hum Mutat 23 (1): 47-56. doi:10.1002/humu.10286. PMID 14695532.
  6. ↑ URL: http://www.ncbi.nlm.nih.gov/omim/232400. Accessed on: 25 January 2011.
Retrieved from "https://librepathology.org/w/index.php?title=Glycogen_storage_diseases&oldid=37668"